These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 24045728)

  • 1. Early treatment of ischemic stroke with intravenous tPA reduces disability risk.
    Mitka M
    JAMA; 2013 Sep; 310(11):1111. PubMed ID: 24045728
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid neurological recovery after intravenous tissue plasminogen activator in stroke: prognostic factors and outcome.
    Machumpurath B; Davis SM; Yan B
    Cerebrovasc Dis; 2011; 31(3):278-83. PubMed ID: 21178353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating as early as possible with thrombolysis is crucial, but can we do better in the sub-4.5-hour time window?
    Parsons MW
    Cerebrovasc Dis; 2011; 31(3):229. PubMed ID: 21178346
    [No Abstract]   [Full Text] [Related]  

  • 4. tPA for stroke: important progress in achieving faster treatment.
    Grotta JC
    JAMA; 2014 Apr 23-30; 311(16):1615-7. PubMed ID: 24756509
    [No Abstract]   [Full Text] [Related]  

  • 5. Worldwide reported use of IV tissue plasminogen activator for acute ischemic stroke.
    Berkowitz AL; Mittal MK; McLane HC; Shen GC; Muralidharan R; Lyons JL; Shinohara RT; Shuaib A; Mateen FJ
    Int J Stroke; 2014 Apr; 9(3):349-55. PubMed ID: 24207029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of intravenous tissue plasminogen activator for ischemic stroke: are there sex differences?
    Allen NB; Myers D; Watanabe E; Dostal J; Sama D; Goldstein LB; Lichtman JH
    Cerebrovasc Dis; 2009; 27(3):254-8. PubMed ID: 19176959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent ischemic stroke can happen in stroke patients very early after intravenous thrombolysis.
    Kamal H; Mowla A; Farooq S; Shirani P
    J Neurol Sci; 2015 Nov; 358(1-2):496-7. PubMed ID: 26375625
    [No Abstract]   [Full Text] [Related]  

  • 8. Transient ischemic attack after tissue plasminogen activator: aborted stroke or unnecessary stroke therapy?
    Uchino K; Massaro L; Hammer MD
    Cerebrovasc Dis; 2010; 29(1):57-61. PubMed ID: 19893313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating the elderly stroke patient: complications, controversies, and best care metrics.
    Heitsch LE; Panagos PD
    Clin Geriatr Med; 2013 Feb; 29(1):231-55. PubMed ID: 23177609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers to the use of intravenous tissue plasminogen activator for in-hospital strokes.
    Bunch ME; Nunziato EC; Labovitz DL
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):808-11. PubMed ID: 21640608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Day-90 acute ischemic stroke outcomes can be derived from early functional activity level.
    Ovbiagele B; Saver JL
    Cerebrovasc Dis; 2010; 29(1):50-6. PubMed ID: 19893312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large-Vessel Occlusion Stroke: Effect of Recanalization on Outcome Depends on the National Institutes of Health Stroke Scale Score.
    Skagen K; Skjelland M; Russell D; Jacobsen EA
    J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1532-9. PubMed ID: 25922156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aphasia predicts unfavorable outcome in mild ischemic stroke patients and prompts thrombolytic treatment.
    Nesi M; Lucente G; Nencini P; Fancellu L; Inzitari D
    J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):204-8. PubMed ID: 23352114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin use and functional outcome after tissue plasminogen activator treatment in acute ischaemic stroke.
    Miedema I; Uyttenboogaart M; Koopman K; De Keyser J; Luijckx GJ
    Cerebrovasc Dis; 2010 Feb; 29(3):263-7. PubMed ID: 20090317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
    Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
    Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator.
    Xian Y; Liang L; Smith EE; Schwamm LH; Reeves MJ; Olson DM; Hernandez AF; Fonarow GC; Peterson ED
    JAMA; 2012 Jun; 307(24):2600-8. PubMed ID: 22735429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative.
    Fonarow GC; Zhao X; Smith EE; Saver JL; Reeves MJ; Bhatt DL; Xian Y; Hernandez AF; Peterson ED; Schwamm LH
    JAMA; 2014 Apr 23-30; 311(16):1632-40. PubMed ID: 24756513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclusion of ischemic stroke patients from intravenous tissue plasminogen activator treatment for mild symptoms should not be based on low National Institutes of Health Stroke Scale Scores.
    Wendt M; Tütüncü S; Fiebach JB; Scheitz JF; Audebert HJ; Nolte CH
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):550-3. PubMed ID: 23433783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue plasminogen activator overdose in acute ischemic stroke patients linked to poorer functional outcomes.
    Sahlas DJ; Gould L; Swartz RH; Mohammed N; McNicoll-Whiteman R; Naufal F; Oczkowski W
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):155-9. PubMed ID: 23375748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombolysis at 3-4.5 hours after acute ischemic stroke onset--evidence from the Canadian Alteplase for Stroke Effectiveness Study (CASES) registry.
    Shobha N; Buchan AM; Hill MD;
    Cerebrovasc Dis; 2011; 31(3):223-8. PubMed ID: 21178345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.